Reports for TOCILIZUMAB
Ingredient
TOCILIZUMAB
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACTEMRA | 162MG | SOLUTION | Resolved | 2022-03-04 | 2022-12-07 | 156092 |
ACTEMRA | 162MG | SOLUTION | Resolved | 2022-03-31 | 2022-12-07 | 157625 |
ACTEMRA | 80MG | SOLUTION | Avoided shortage | 2021-08-20 | 2022-07-20 | 144365 |
ACTEMRA | 200MG | SOLUTION | Avoided shortage | 2022-02-17 | 2022-07-20 | 155146 |
ACTEMRA | 400MG | SOLUTION | Avoided shortage | 2021-08-23 | 2022-07-20 | 144440 |
ACTEMRA | 200MG | SOLUTION | Resolved | 2021-08-23 | 2021-12-10 | 144437 |
ACTEMRA | 162MG | SOLUTION | Resolved | 2021-07-13 | 2021-11-26 | 142457 |
ACTEMRA | 162MG | SOLUTION | Avoided shortage | 2021-07-12 | 2021-11-25 | 142322 |
Showing 1 to 8 of 8
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0